ERNA-101 is designed to activate and enhance the immune system's response to recognize and attack cancer cells. Our best-in-class, synthetic iMSCs represent a new class of precision-guided therapeutics, taking advantage of the MSC’s natural tumor-homing abilities to migrate directly to tumor sites, allowing them to slip through the tumor’s defenses and infiltrate tumor tissue.